[HTML][HTML] Membranous nephropathy: systems biology-based novel mechanism and traditional Chinese medicine therapy

H Miao, Y Zhang, X Yu, L Zou, Y Zhao - Frontiers in Pharmacology, 2022 - frontiersin.org
Membranous nephropathy (MN) is a renal-limited non-inflammatory autoimmune disease in
the glomerulus, which is the second or third main cause of end-stage kidney diseases in …

[HTML][HTML] Urinary protein and peptide markers in chronic kidney disease

N Chebotareva, A Vinogradov, V McDonnell… - International journal of …, 2021 - mdpi.com
Chronic kidney disease (CKD) is a non-specific type of kidney disease that causes a gradual
decline in kidney function (from months to years). CKD is a significant risk factor for death …

[HTML][HTML] Novel biomarkers in membranous nephropathy

Q Liu, J Liu, B Lin, Y Zhang, M Ma, M Yang… - Frontiers in …, 2022 - frontiersin.org
Membranous nephropathy (MN) is the main cause of adult nephrotic syndrome (NS). The
pathogenesis of MN is complex and involves subepithelial immune complex deposition …

Proteasuria—the impact of active urinary proteases on sodium retention in nephrotic syndrome

F Artunc, M Wörn, A Schork, BN Bohnert - Acta physiologica, 2019 - Wiley Online Library
Sodium retention and extracellular volume expansion are typical features of patients with
nephrotic syndrome. In recent years, from in vitro data, endoluminal activation of the …

[HTML][HTML] Proteomic analysis of human serum from patients with chronic kidney disease

Y Romanova, A Laikov, M Markelova, R Khadiullina… - Biomolecules, 2020 - mdpi.com
Chronic kidney disease (CKD) is an important public health problem in the world. The aim of
our research was to identify novel potential serum biomarkers of renal injury. ELISA assay …

[HTML][HTML] Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA …

A Taherkhani, R Farrokhi Yekta, M Mohseni… - Proteome science, 2019 - Springer
Abstract Chronic Kidney Disease (CKD) is a global health problem annually affecting
millions of people around the world. It is a comprehensive syndrome, and various factors …

Proteasuria in nephrotic syndrome–quantification and proteomic profiling

M Wörn, BN Bohnert, F Alenazi, K Boldt, F Klose… - Journal of …, 2021 - Elsevier
Nephrotic syndrome is characterized by urinary excretion of plasma proteases or
proteasuria. There is a lack of data on the quantity, activity status and identity of these …

Progress in understanding primary glomerular disease: insights from urinary proteomics and in-depth analyses of potential biomarkers based on bioinformatics

L Ge, J Liu, B Lin, X Qin - Critical Reviews in Clinical Laboratory …, 2023 - Taylor & Francis
Chronic kidney disease (CKD) has become a global public health challenge. While primary
glomerular disease (PGD) is one of the leading causes of CKD, the specific pathogenesis of …

[HTML][HTML] Targeted MRM quantification of urinary proteins in chronic kidney disease caused by glomerulopathies

AS Kononikhin, AG Brzhozovskiy, AE Bugrova… - Molecules, 2023 - mdpi.com
Glomerulopathies with nephrotic syndrome that are resistant to therapy often progress to
end-stage chronic kidney disease (CKD) and require timely and accurate diagnosis …

[HTML][HTML] Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies

F Zanoni, M Abinti, M Belingheri… - International Journal of …, 2023 - mdpi.com
IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immune-mediated
glomerular diseases with highly variable prognosis. Current guidelines recommend that …